Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2024 (1)
  • 2023 (1)
  • 2022 (1)

Subject

  • Prescription Drugs (13)
  • Drug Trafficking (7)
  • Pharmaceuticals/Pharmacists/Physicians (7)
  • Diversion Division (6)
  • Synthetic drugs (3)
  • Task Forces/Task Force Officers (3)
  • Arrests/Convictions - Major (2)
  • Major Law Enforcement Operation (2)
  • Outreach/Drug Prevention (2)
  • Seizures (Drugs/Property) (2)
  • Fake Pills (1)
  • Guilty Plea (1)
  • Guns/Weapons (1)
  • Prevention/Education - DEA websites GSAD, JTT etc (1)
  • Public and Media Affairs - also see Congressional Affairs (1)
  • Overdose (3)

Drug Name

  • Fentanyl (206)
  • Heroin (47)
  • Cocaine (38)
  • Methamphetamine (23)
  • Synthetic Opioids (23)
  • Opioids (16)
  • Oxycodone (14)
  • Marijuana (Cannabis) (6)
  • Hydromorphone (3)
  • Ecstasy/MDMA (2)
  • K2/Spice (2)
  • Marijuana Concentrates (2)
  • Morphine (2)
  • Ketamine (1)
  • Methadone (1)
  • Synthetic Bath Salts or Designer Cathinones (1)
  • Benzodiazepines (3)
  • LSD (0)

Field Division

  • Washington, DC (2)
  • Los Angeles (1)
Clear All Results
PRESS RELEASE

Santa Clarita Man Charged with Distributing Opioid More Powerful than Fentanyl and Causing Victim’s Overdose Death

Noviembre 22, 2024
LOS ANGELES – A Santa Clarita man has been arraigned on an indictment alleging he distributed protonitazene – a novel synthetic opioid that is up to three times more powerful than fentanyl – which resulted in a victim’s fatal overdose this spring, the Justice Department announced today. Benjamin Anthony Collins...
Noviembre 22, 2024
PRESS RELEASE

Consent Decree Approved Among the U.S. and Cumberland, M.D. based Pharmacy and Pharmacist

Julio 06, 2023
Baltimore, Maryland - U.S. District Judge Lydia K. Griggsby approved the United States’ consent decree with John A. Beckman, a Cumberland, Maryland based pharmacist, and Beckman’s Greene Street Pharmacy, Inc. (“Beckman’s Pharmacy”), resolving the United States’ civil allegations that Beckman and Beckman’s Pharmacy violated the Controlled Substances Act (“CSA”) in...
Julio 06, 2023
PRESS RELEASE

DEA Serves Immediate Suspension Order on Northgate Pharmacy in Waldorf, Maryland

Enero 27, 2022
Washington, D.C., - Jarod Forget, Special Agent in Charge of the DEA Washington Division, announced the issuance of an Immediate Suspension Order (ISO) at Northgate Pharmacy, located at 3973 Saint Charles Parkway, Waldorf, Maryland, today. This morning, members of the Drug Enforcement Administration (DEA) Washington Division’s Tactical Diversion Squad, along...
Enero 27, 2022
Showing 1 - 3 of 3 results

SAMHSA Behavioral Health Treatment Locator

  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Quiénes somos
  • Recursos
Back
  • Sobre la DEA
  • Mission
  • Nuestra historia
  • Divisiones Nacionales
  • DEA Museum
  • Wall of Honor
  • Contáctenos
Back
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Ley de Libertad de Información
  • Publications
  • Galerías Multimedia
  • Programa de Asistencia a Testigos para Víctimas
Back
  • Fee Waiver
Back
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español